Bladder cancer and cyclophosphamide. Three cases and a review of the literature;Cancer de vessie et cyclophosphamide. A propos de trois cas et revue de la litterature

Bulletin du Cancer

Volumn 83, Issue 11, 1996, Pages 945-950

  Alexandre, J ^a   Levy V ^a   Hunault, M ^a   Bazarbachi, A ^a   Delmer, A ^a   Rio, B ^a   Zittoun, R ^a  

^a HÔTEL DIEU   (France)

Author keywords

bladder carcinoma; cyclophosphamide; secondary cancer

Indexed keywords

CYCLOPHOSPHAMIDE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CASE REPORT; FEMALE; HUMAN; MALE; WALDENSTROEM MACROGLOBULINEMIA;

AGED; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYSTITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMATURIA; HUMANS; MALE; MIDDLE AGED; RED-CELL APLASIA, PURE; RISK FACTORS; URINARY BLADDER NEOPLASMS; WALDENSTROM MACROGLOBULINEMIA;

EID: 0029807437     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Albanell J, Gallego OS, Bellmunt J et al. Bladder Neoplasm in a patient with panarteris nodosa treated with cyclophosphamide. Rev Clin Esp 1992;9:463-5
2. Alivizatos G, Dimopoulou I, Mitropoulos D et al. Bladder Cancer in a young girl with systemic lupus erythematosus treated with cyclophosphamide. Acta Oncol Belg 1991; 59:133-7
3. Bjergaard JP, Ersboll DJ, Hansen VL et al. Carcinoma of the urinary bladder after treatement with cyclophosphamide for non-Hodgkin's Lymphoma. N Engl J Med 1988;318: 1028-32
4. Boffeta P, Kaldor JM. Secondary malignancies following cancer chemotherapy. Acta Oncol 1994;6:591-8
5. Calabresi P, Parks RE Jr. Alkylating agents, antimetabolites, hormones, and other antiproliferative agents. In: LS Goodman, A Oilman, eds. The Pharmacological Basis of Therapeutics, 5th ed. New York: Macmillan Publishing Co, 1992:1216-8
6. Cannon J, Linke CA, Cos LR. Cyclophosphamide-associated carcinoma of urothelium : modalities for prevention. Urology 1991;38:413-6
7. Castor CW, Bull FE. Review of United States data on neoplasms in rheumatoid arthritis. Am J Med 1985;78:33-8
8. Cohen SM, Garland EM, St John M et al. Acrolein initiates rat urinary bladder carcinogenesis. Cancer Res 1992;52: 3577-81
9. De Castro Barbosa F, Rosell Costa D, Aguera Femandez L et al. Tumors of the upper urothelium and cyclophosphamide: presentation of a case and review of the litterature. Arch Esp Urol 1991;44:1149-51
10. Donadio JV, Glassock RJ. Immunosuppressive drug therapy in lupus nephritis. Am J Kidney Dis 1993:3:239-49
11. Dore B, Grange P, Aubert J. Cancer de vessie après cystite due au cyclophosphamide: À propos d'un cas. J Urol (Paris) 1989;95:427-31
12. Dumas P, Roulet B, Colombeau P, Loubet R. Cancers urothéliaux sous Endoxan. J Urol 1984;90:411-2
13. Esrig D, Elmajian D, Groshen S et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 1994;331:1259-64
14. Fairchild WV, Spence CR, Solomon HD, Gangai MP. The incidence of bladder cancer after cyclophosphamide therapy. J Urol 1979:122:163-4
15. Habs M, Schmahl D. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (Mesna®) and disodium 2,2'-dithiobis-ethane sulfonate (Dimesna®). Cancer 1983;51: 606-9
16. Iwabuchi A, Hohjoh H, Fujieda H et al. Bladder carcinoma in a case of multiple myeloma IgG treated with cyclophosphamide: review of litterature. Jpn J Clin Hematol 1988; 29:1272-6
17. Levine E. Transitional cell carcinoma of the renal pelvis associated with cyclophosphamide therapy. Am J Roentgenoll 992;159:1027-8
18. Lupera H, Droz JP, Culine JP et al. Cancer de la vessie après traitement par cyclophosphamide: À propos d'un cas et revue de la littérature. J Urol 1990;96:48-52
19. e éd. Paris: Expansion Scientifique Française, 1989:1918: 19-20
20. McDougal WS, Cramer SF, Miller R. Invasive carcinoma of the renal pelvis following cyclophosphamide therapy for nonmalignant Disease. Cancer 1981;48:691-5
21. O'Keane JC. Carcinoma of the urinary bladder after treatement with cyclophosphamide. N Engl J Med 1988;319:871
22. Ortiz A, Gonzalez-Parra E, Alvarez-Costa G, Egido J. Bladder cancer after cyclophosphamide therapy for lupus nephritis. Nephron 1992;60:378-9
23. Patterson WP, Reams GP. Renal toxicities of chemotherapy. Semin Oncol 1992; 19:523-1
24. Ramada Benlloch FJ, Gonzalvo Perez V, Blasco Alfonso E et al. Urothelial carcinoma after treatment with cyclophosphamide, review of the litterature and presentation of our caseload. Acta Urol Esp 1993;17:139-42
25. Samra Y, Hertz M, Lindner A. Urinary bladder tumors following cyclophosphamide therapy :a report of two cases with a review of the litterature. Med Pediatr Oncol 1985; 13:86-91
26. SchmähL, D, Habs M. Carcinogenic action of low-dose cyclophosphamide given orally to sprague-dawley rats in a lifetime experiment. Int J Cancer 1979;23:706-12
27. Seo S, Clark SA, McGovern FD et al. Leimyosarcoma of the urinary bladder 13 years after cyclophosphamide therapy for Hodgkin's disease. Cancer 1985;55:1597-603
28. Shepherd JD, Pringle LE, Barnett MJ et al. Mesna versus hyperhydratation for the prevention of cyclophosphamideinduced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol 1991;9:2016-20
29. Shiba T, Noguchi S, Yao M. Carcinoma of the urinary bladder in a patient receiving cyclophosphamide for Wegener's granuloma: a case report. Acta Urol Jpn 1991;37:393-6
30. Sigal SH, Tomaszewski JE, Brooks JJ et al. Carcinosarcoma of bladder following long-term cyclophosphamide therapy. Arch Pathol Lab Med 1991 ; 115:1049-51
31. Stein JP, Skinner EC, Boyd SD, Skinner DG. Squamous cell carcinoma of the bladder associated with cyclophosphamide therapy for Wegener's granulomatosis: a report of two cases. 7 Urol 1993;149:588-9
32. Stilwell TJ, Benson RC. Cyclophosphamide-induced hemorrhagic cystitis, a review of 100 patients. Cancer 1988;61:451-7
33. Thrasher JB, Miller GJ, Wettlaufer JN. Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis. J Urol 1990;143:119-21
34. Travis LB, Curtis RE, Boice JD Jr. Fraumeni JF Jr. Bladder cancer after chemotherapy for non-Hogkin's lymphoma. N Engl J Med 1989;321:544-5
35. Tuttle TM, Williams GM, Marshal FF. Evidence for cyclophosphamide-induced transitional cell carcinoma in a renal transplant patient. J Urol 1988:140:1009-11
36. Worth PHL. Cyclophosphamide and the bladder. Dr J Med 1971:284:90
37. Yoshimoto K, Hisamochi A, Ogata H et al. Urinary bladder carcinoma was induced in a patient treated with cyclophosphamide for malignant lymphoma. Jpn J Clin Hematol 1994;35:300-3